American Heart Association
The American Heart Association is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
EMPEROR Reduced Trial: Should You Use Empagliflozin in HFrEF With or Without Diabetes?
By
American Heart Association
FEATURING
Milton Packer
By
American Heart Association
FEATURING
Milton Packer
Login to view comments.
Click here to Login